{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:38:05Z","timestamp":1786538285353,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82104170"],"award-info":[{"award-number":["82104170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270815"],"award-info":[{"award-number":["82270815"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the special funds of the clinical research from the Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University","award":["QYRYCRC2023016"],"award-info":[{"award-number":["QYRYCRC2023016"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2024A1515013233"],"award-info":[{"award-number":["2024A1515013233"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04364-6","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T09:04:12Z","timestamp":1780736652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-dimensional profiling of lactylation-related signatures for prognostic and therapeutic insights in bladder cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Hongjun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chubiao","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanfang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"4364_CR1","doi-asserted-by":"crossref","unstructured":"Richters A, Aben KKH, Kiemeney L. The global burden of urinary bladder cancer: an update. In: World J Urol. vol. 38. Germany; 2020: 1895\u20131904.","DOI":"10.1007\/s00345-019-02984-4"},{"issue":"3","key":"4364_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10061","key":"4364_CR3","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstrom PU, Choi W, Guo CC, Lotan Y, Kassouf W. Bladder cancer. Lancet. 2016;388(10061):2796\u2013810.","journal-title":"Lancet"},{"issue":"5","key":"4364_CR4","first-page":"404","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404\u201323.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4364_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carrion A, Cathomas R, Comperat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A, Martini A, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol. 2024;85(1):17\u201331.","journal-title":"Eur Urol"},{"key":"4364_CR6","doi-asserted-by":"crossref","unstructured":"Pardo JC, Ruiz de Porras V, Plaja A, Carrato C, Etxaniz O, Buisan O, Font A. Moving towards Personalized Medicine in Muscle-Invasive Bladder Cancer: Where Are We Now and Where Are We Going? In: Int J Mol Sci. vol. 21. Switzerland; 2020.","DOI":"10.3390\/ijms21176271"},{"issue":"10064","key":"4364_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","volume":"389","author":"AV Balar","year":"2017","unstructured":"Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J, Loriot Y, Necchi A, Hoffman-Censits J, Perez-Gracia JL, et al. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Lancet. 2017;389(10064):67\u201376.","journal-title":"Lancet"},{"key":"4364_CR8","doi-asserted-by":"crossref","unstructured":"Necchi A, Joseph RW, Loriot Y, Hoffman-Censits J, Perez-Gracia JL, Petrylak DP, Derleth CL, Tayama D, Zhu Q, Ding B et al. Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study. In: Ann Oncol. vol. 28. England; 2017: 3044\u20133050.","DOI":"10.1093\/annonc\/mdx518"},{"issue":"7","key":"4364_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","volume":"22","author":"T Powles","year":"2021","unstructured":"Powles T, Csoszi T, Ozguroglu M, Matsubara N, Geczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, et al. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(7):931\u201345.","journal-title":"Lancet Oncol"},{"issue":"2","key":"4364_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.eururo.2022.04.013","volume":"82","author":"B Szabados","year":"2022","unstructured":"Szabados B, Kockx M, Assaf ZJ, van Dam PJ, Rodriguez-Vida A, Duran I, Crabb SJ, Van Der Heijden MS, Pous AF, Gravis G, et al. Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder. Eur Urol. 2022;82(2):212\u201322.","journal-title":"Eur Urol"},{"key":"4364_CR11","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. In: Cell. vol. 144. United States; 2011: 646\u2013674.","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"4364_CR12","doi-asserted-by":"crossref","unstructured":"Moreno-Yruela C, Zhang D, Wei W, Baek M, Liu W, Gao J, Dankova D, Nielsen AL, Bolding JE, Yang L, et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. In: Sci Adv. Volume 8. United States; 2022. p. eabi6696.","DOI":"10.1126\/sciadv.abi6696"},{"key":"4364_CR13","doi-asserted-by":"crossref","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M et al. Metabolic regulation of gene expression by histone lactylation. In: Nature. vol. 574. England; 2019: 575\u2013580.","DOI":"10.1038\/s41586-019-1678-1"},{"key":"4364_CR14","doi-asserted-by":"crossref","unstructured":"Li F, Si W, Xia L, Yin D, Wei T, Tao M, Cui X, Yang J, Hong T, Wei R. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. In: Mol Cancer. vol. 23. England; 2024: 90.","DOI":"10.1186\/s12943-024-02008-9"},{"issue":"8","key":"4364_CR15","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.cmet.2024.07.011","volume":"36","author":"G Li","year":"2024","unstructured":"Li G, Wang D, Zhai Y, Pan C, Zhang J, Wang C, Huang R, Yu M, Li Y, Liu X, et al. Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma. Cell Metab. 2024;36(8):1696\u2013710. e1610.","journal-title":"Cell Metab"},{"issue":"9","key":"4364_CR16","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, Wang H, Song Y, Du Y, Cui B, et al. Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82(9):1660\u201377. e1610.","journal-title":"Mol Cell"},{"key":"4364_CR17","doi-asserted-by":"crossref","unstructured":"Xie B, Lin J, Chen X, Zhou X, Zhang Y, Fan M, Xiang J, He N, Hu Z, Wang F. CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. In: Mol Cancer. vol. 22. England; 2023: 151.","DOI":"10.1186\/s12943-023-01856-1"},{"key":"4364_CR18","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, Cao C, Wang Q, Zhao X, Huang Z, et al. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 2024;73:101059.","journal-title":"Drug Resist Updat"},{"key":"4364_CR19","doi-asserted-by":"crossref","unstructured":"Wang R, Xu F, Yang Z, Cao J, Hu L, She Y. The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation. In: BMC Urol. vol. 24. England; 2024: 59.","DOI":"10.1186\/s12894-024-01444-5"},{"key":"4364_CR20","doi-asserted-by":"publisher","first-page":"114119","DOI":"10.1016\/j.intimp.2025.114119","volume":"148","author":"X Deng","year":"2025","unstructured":"Deng X, Huang Y, Zhang J, Chen Y, Jiang F, Zhang Z, Li T, Hou L, Tan W, Li F. Histone lactylation regulates PRKN-Mediated mitophagy to promote M2 Macrophage polarization in bladder cancer. Int Immunopharmacol. 2025;148:114119.","journal-title":"Int Immunopharmacol"},{"key":"4364_CR21","doi-asserted-by":"crossref","unstructured":"Wan N, Wang N, Yu S, Zhang H, Tang S, Wang D, Lu W, Li H, Delafield DG, Kong Y, et al. Cyclic immonium ion of lactyllysine reveals widespread lactylation in the human proteome. In: Nat Methods. Volume 19. United States; 2022. pp. 854\u201364.","DOI":"10.1038\/s41592-022-01523-1"},{"key":"4364_CR22","doi-asserted-by":"crossref","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. In: Bioinformatics. vol. 26. England; 2010: 1572\u20131573.","DOI":"10.1093\/bioinformatics\/btq170"},{"key":"4364_CR23","doi-asserted-by":"crossref","unstructured":"Dai H. Friend or foe? Multi-omics analysis unravels the complex identity of key pyroptosis factor CASP9 in clear cell renal cell carcinoma. Clin Cancer Bull 2025;4(1):18.","DOI":"10.1007\/s44272-025-00047-x"},{"key":"4364_CR24","doi-asserted-by":"crossref","unstructured":"Dai H, Zhao K, Zhao Y, Jiang K, Hang Z, Huang X, Luo W, Nie J, Qin C, Zhou W. Machine learning model in multi-omics perspective demystifies the prognostic significance of crotonylation heterogeneity in clear cell renal cell carcinoma. In: BMC Urol. vol. 25. England; 2025: 229.","DOI":"10.1186\/s12894-025-01914-4"},{"issue":"6","key":"4364_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K, Svekolkin V, Gafurov A, Isaeva O, Osokin N, Kozlov I, Frenkel F, Gancharova O, et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021;39(6):845\u201365. e847.","journal-title":"Cancer Cell"},{"issue":"4","key":"4364_CR26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, et al. The Immune Landscape of Cancer. Immunity. 2018;48(4):812\u2013e830814.","journal-title":"Immunity"},{"key":"4364_CR27","doi-asserted-by":"crossref","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. In: Nat Med. vol. 24. United States; 2018: 1550\u20131558.","DOI":"10.1038\/s41591-018-0136-1"},{"key":"4364_CR28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res vol. 2018;28:1747\u201356. United States.","journal-title":"Genome Res vol"},{"issue":"1","key":"4364_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, Hackl H, Trajanoski Z. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"key":"4364_CR30","doi-asserted-by":"crossref","unstructured":"Dai H, Wang X, Wu Q, Tan Y, Shen H, Gu Y, Su C, Chen A. Integrating genetic crosstalk between atherosclerosis and lung adenocarcinoma to advance precision diagnosis and treatment. In: Cell Div. vol. 20. England; 2025: 27.","DOI":"10.1186\/s13008-025-00172-y"},{"issue":"12","key":"4364_CR31","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ijc.33794","volume":"149","author":"H Lai","year":"2021","unstructured":"Lai H, Cheng X, Liu Q, Luo W, Liu M, Zhang M, Miao J, Ji Z, Lin GN, Song W, et al. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int J Cancer. 2021;149(12):2099\u2013115.","journal-title":"Int J Cancer"},{"key":"4364_CR32","doi-asserted-by":"crossref","unstructured":"Li KJ, Hong Y, Yu YZ, Xie Z, Lv DJ, Wang C, Xie T, Chen H, Chen ZS, Zeng J et al. NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8. In: Adv Sci (Weinh). vol. 11. Germany; 2024: e2310131.","DOI":"10.1002\/advs.202310131"},{"key":"4364_CR33","doi-asserted-by":"crossref","unstructured":"Cheng Z, Huang H, Li M, Liang X, Tan Y, Chen Y. Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma. In: Pharmaceuticals (Basel). Volume 16. Switzerland; 2023;16(5):644.","DOI":"10.3390\/ph16050644"},{"key":"4364_CR34","doi-asserted-by":"crossref","unstructured":"Huang H, Chen K, Zhu Y, Hu Z, Wang Y, Chen J, Li Y, Li D, Wei P. A multi-dimensional approach to unravel the intricacies of lactylation related signature for prognostic and therapeutic insight in colorectal cancer. In: J Transl Med. vol. 22. England; 2024: 211.","DOI":"10.1186\/s12967-024-04955-9"},{"key":"4364_CR35","doi-asserted-by":"crossref","unstructured":"Jiao Y, Ji F, Hou L, Lv Y, Zhang J. Lactylation-related gene signature for prognostic prediction and immune infiltration analysis in breast cancer. In: Heliyon. vol. 10. England; 2024: e24777.","DOI":"10.1016\/j.heliyon.2024.e24777"},{"key":"4364_CR36","doi-asserted-by":"crossref","unstructured":"Pan J, Zhang J, Lin J, Cai Y, Zhao Z. Constructing lactylation-related genes prognostic model to effectively predict the disease-free survival and treatment responsiveness in prostate cancer based on machine learning. In: Front Genet. vol. 15. Switzerland; 2024: 1343140.","DOI":"10.3389\/fgene.2024.1343140"},{"issue":"19","key":"4364_CR37","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.3748\/wjg.v30.i19.2575","volume":"30","author":"T Peng","year":"2024","unstructured":"Peng T, Sun F, Yang JC, Cai MH, Huai MX, Pan JX, Zhang FY, Xu LM. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma. World J Gastroenterol. 2024;30(19):2575\u2013602.","journal-title":"World J Gastroenterol"},{"key":"4364_CR38","doi-asserted-by":"crossref","unstructured":"Zhang X, Li Y, Chen Y. Development of a Comprehensive Gene Signature Linking Hypoxia, Glycolysis, Lactylation, and Metabolomic Insights in Gastric Cancer through the Integration of Bulk and Single-Cell RNA-Seq Data. In: Biomedicines. Switzerland; 2023;11(11):2948.","DOI":"10.3390\/biomedicines11112948"},{"key":"4364_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","volume":"45","author":"F Massari","year":"2016","unstructured":"Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, Scarpelli M, Berardi R, Tortora G, Lopez-Beltran A, et al. Metabolic phenotype of bladder cancer. Cancer Treat Rev. 2016;45:46\u201357.","journal-title":"Cancer Treat Rev"},{"key":"4364_CR40","doi-asserted-by":"crossref","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. In: Mol Cancer. vol. 22. England; 2023: 138.","DOI":"10.1186\/s12943-023-01827-6"},{"key":"4364_CR41","doi-asserted-by":"crossref","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, Campbell K, Cano A, Casanova J, Christofori G et al. Guidelines and definitions for research on epithelial-mesenchymal transition. In: Nat Rev Mol Cell Biol. vol. 21. England; 2020: 341\u2013352.","DOI":"10.1038\/s41580-020-0237-9"},{"key":"4364_CR42","doi-asserted-by":"crossref","unstructured":"Schneider AK, Chevalier MF, Derre L. The multifaceted immune regulation of bladder cancer. In: Nat Rev Urol. vol. 16. England; 2019: 613\u2013630.","DOI":"10.1038\/s41585-019-0226-y"},{"key":"4364_CR43","doi-asserted-by":"crossref","unstructured":"Dai H, Yu Z, Zhao Y, Jiang K, Hang Z, Huang X, Ma H, Wang L, Li Z, Wu M et al. Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer. In: Biol Direct. vol. 20. England; 2025: 56.","DOI":"10.1186\/s13062-025-00650-x"},{"key":"4364_CR44","doi-asserted-by":"crossref","unstructured":"Dai H, Zhang X, Zhao Y, Nie J, Hang Z, Huang X, Ma H, Wang L, Li Z, Wu M et al. ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment. In: Hereditas. vol. 162. England; 2025: 42.","DOI":"10.1186\/s41065-025-00409-4"},{"key":"4364_CR45","doi-asserted-by":"crossref","unstructured":"Guo C, Jiang X, Zhang Y, Bao G. Comprehensive analysis of tumor immune-related gene signature for predicting prognosis, immunotherapy, and drug sensitivity in bladder urothelial carcinoma. In: Transl Cancer Res. vol. 13. China; 2024: 6732\u20136752.","DOI":"10.21037\/tcr-24-1053"},{"key":"4364_CR46","doi-asserted-by":"publisher","first-page":"1481296","DOI":"10.3389\/fimmu.2024.1481296","volume":"15","author":"T Yang","year":"2024","unstructured":"Yang T, Luo W, Yu J, Zhang H, Hu M, Tian J. Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis. Front Immunol. 2024;15:1481296.","journal-title":"Front Immunol"},{"key":"4364_CR47","doi-asserted-by":"publisher","first-page":"1258951","DOI":"10.3389\/fonc.2023.1258951","volume":"13","author":"S Zhang","year":"2023","unstructured":"Zhang S, Cai Z, Li H. AHNAKs roles in physiology and malignant tumors. Front Oncol. 2023;13:1258951.","journal-title":"Front Oncol"},{"key":"4364_CR48","doi-asserted-by":"crossref","unstructured":"Lee H, Kim K, Woo J, Park J, Kim H, Lee KE, Kim H, Kim Y, Moon KC, Kim JY et al. Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology. In: Mol Cell Proteomics. vol. 17. United States; 2018: 1788\u20131802.","DOI":"10.1074\/mcp.RA118.000562"},{"key":"4364_CR49","doi-asserted-by":"crossref","unstructured":"Kim JY, Sim H, Na AY, Choi SY, Lee S. Global Profiling of Lysine Lactylation in Prostate Cancer Cells. In: Cancer Genomics Proteomics. vol. 22. Greece; 2025: 929\u2013939.","DOI":"10.21873\/cgp.20547"},{"key":"4364_CR50","doi-asserted-by":"publisher","first-page":"918778","DOI":"10.3389\/fonc.2022.918778","volume":"12","author":"H Yue","year":"2022","unstructured":"Yue H, Hu Z, Hu R, Guo Z, Zheng Y, Wang Y, Zhou Y. ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism. Front Oncol. 2022;12:918778.","journal-title":"Front Oncol"},{"key":"4364_CR51","doi-asserted-by":"crossref","unstructured":"Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu Z, Stass SA, Jiang F. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. In: Cancer Epidemiol Biomarkers Prev. vol. 19. United States; 2010: 327\u2013337.","DOI":"10.1158\/1055-9965.EPI-09-0865"},{"key":"4364_CR52","doi-asserted-by":"crossref","unstructured":"Wang M, Wang T, Wang J, Yang Y, Li X, Chen H, Liao J. ALDH1A1 promotes immune escape of tumor cells through ZBTB7B-glycolysis pathway. In: Cell Death Dis. vol. 15. England; 2024: 568.","DOI":"10.1038\/s41419-024-06943-9"},{"key":"4364_CR53","doi-asserted-by":"crossref","unstructured":"Michalak M. Calreticulin: Endoplasmic reticulum Ca(2+) gatekeeper. In: J Cell Mol Med. vol. 28. England; 2024: e17839.","DOI":"10.1111\/jcmm.17839"},{"key":"4364_CR54","doi-asserted-by":"crossref","unstructured":"Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M. Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. In: Biochem J. vol. 417. England; 2009: 651\u2013666.","DOI":"10.1042\/BJ20081847"},{"key":"4364_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-3-030-67696-4_7","volume":"59","author":"A Venkatesan","year":"2021","unstructured":"Venkatesan A, Satin LS, Raghavan M. Roles of Calreticulin in Protein Folding, Immunity, Calcium Signaling and Cell Transformation. Prog Mol Subcell Biol. 2021;59:145\u201362.","journal-title":"Prog Mol Subcell Biol"},{"key":"4364_CR56","doi-asserted-by":"crossref","unstructured":"Kageyama S, Isono T, Iwaki H, Wakabayashi Y, Okada Y, Kontani K, Yoshimura K, Terai A, Arai Y, Yoshiki T. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. In: Clin Chem. vol. 50. England; 2004: 857\u2013866.","DOI":"10.1373\/clinchem.2003.027425"},{"key":"4364_CR57","doi-asserted-by":"crossref","unstructured":"Lu YC, Chen CN, Wang B, Hsu WM, Chen ST, Chang KJ, Chang CC, Lee H. Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression. In: Am J Pathol. vol. 179. United States; 2011: 1425\u20131433.","DOI":"10.1016\/j.ajpath.2011.05.015"},{"key":"4364_CR58","doi-asserted-by":"crossref","unstructured":"Maier T, Guell M, Serrano L. Correlation of mRNA and protein in complex biological samples. In: FEBS Lett. vol. 583. England; 2009: 3966\u20133973.","DOI":"10.1016\/j.febslet.2009.10.036"},{"key":"4364_CR59","doi-asserted-by":"crossref","unstructured":"Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. In: Nat Rev Genet. vol. 13. England; 2012: 227\u2013232.","DOI":"10.1038\/nrg3185"},{"key":"4364_CR60","doi-asserted-by":"crossref","unstructured":"Zhang Z, Wang Y, Liang Z, Meng Z, Zhang X, Ma G, Chen Y, Zhang M, Su Y, Li Z et al. Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression. In: iScience. vol. 26. United States; 2023: 108142.","DOI":"10.1016\/j.isci.2023.108142"},{"issue":"5","key":"4364_CR61","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1139\/o98-091","volume":"76","author":"M Michalak","year":"1998","unstructured":"Michalak M, Mariani P, Opas M. Calreticulin, a multifunctional Ca2\u2009+\u2009binding chaperone of the endoplasmic reticulum. Biochem Cell Biol. 1998;76(5):779\u201385.","journal-title":"Biochem Cell Biol"},{"key":"4364_CR62","doi-asserted-by":"crossref","unstructured":"McDonough AA, Veiras LC, Minas JN, Ralph DL. Considerations when quantitating protein abundance by immunoblot. In: Am J Physiol Cell Physiol. vol. 308. United States; 2015: C426\u2013433.","DOI":"10.1152\/ajpcell.00400.2014"},{"key":"4364_CR63","doi-asserted-by":"crossref","unstructured":"Pillai-Kastoori L, Heaton S, Shiflett SD, Roberts AC, Solache A, Schutz-Geschwender AR. Antibody validation for Western blot: By the user, for the user. In: J Biol Chem. vol. 295. United States; 2020: 926\u2013939.","DOI":"10.1016\/S0021-9258(17)49905-4"},{"key":"4364_CR64","doi-asserted-by":"crossref","unstructured":"Huang J, Zhang L, Wan D, Zhou L, Zheng S, Lin S, Qiao Y. Extracellular matrix and its therapeutic potential for cancer treatment. In: Signal Transduct Target Ther. vol. 6. England; 2021: 153.","DOI":"10.1038\/s41392-021-00544-0"},{"key":"4364_CR65","doi-asserted-by":"crossref","unstructured":"Chen L, Huang L, Gu Y, Cang W, Sun P, Xiang Y. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression. In: Int J Mol Sci. vol. 23. Switzerland; 2022.","DOI":"10.3390\/ijms231911943"},{"issue":"3","key":"4364_CR66","doi-asserted-by":"publisher","first-page":"111122","DOI":"10.1016\/j.celrep.2022.111122","volume":"40","author":"J Gu","year":"2022","unstructured":"Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X, Shao Q, Zhou B, Zhou H, Wei S, et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-beta signaling in regulatory T cells. Cell Rep. 2022;40(3):111122.","journal-title":"Cell Rep"},{"key":"4364_CR67","doi-asserted-by":"publisher","first-page":"103209","DOI":"10.1016\/j.redox.2024.103209","volume":"74","author":"X Gu","year":"2024","unstructured":"Gu X, Zhu Y, Su J, Wang S, Su X, Ding X, Jiang L, Fei X, Zhang W. Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression. Redox Biol. 2024;74:103209.","journal-title":"Redox Biol"},{"key":"4364_CR68","doi-asserted-by":"crossref","unstructured":"Raychaudhuri D, Singh P, Chakraborty B, Hennessey M, Tannir AJ, Byregowda S, Natarajan SM, Trujillo-Ocampo A, Im JS, Goswami S. Histone lactylation drives CD8(+) T cell metabolism and function. In: Nat Immunol. Volume 25. United States; 2024. pp. 2140\u201351.","DOI":"10.1038\/s41590-024-01985-9"},{"key":"4364_CR69","doi-asserted-by":"crossref","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. In: Nat Rev Cancer. vol. 16. England; 2016: 582\u2013598.","DOI":"10.1038\/nrc.2016.73"},{"key":"4364_CR70","doi-asserted-by":"crossref","unstructured":"Crocetto F, Amicuzi U, Musone M, Magliocchetti M, Di Lieto D, Tammaro S, Pastore AL, Fuschi A, Falabella R, Ferro M et al. Liquid Biopsy: Current advancements in clinical practice for bladder cancer. In: J Liq Biopsy. vol. 9. United States; 2025: 100310.","DOI":"10.1016\/j.jlb.2025.100310"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04364-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04364-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04364-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:06:06Z","timestamp":1786536366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04364-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4364"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04364-6","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"281"}}